Thrombolysis in Myocardial Infarction Study Group

Academic/HospitalWebsite ↗

Also known as: The Thrombolysis in Myocardial Infarction Study (TIMI) Group | The TIMI (Thrombolysis in Myocardial Infarction) Study Group | Thrombolysis in Myocardial Infarction (TIMI) Study Group

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Sep 1, 2007

Last known activity

Nov 4, 2020

Timeline

1980s

Jan 1, 1984
Thrombolysis in Myocardial Infarction Study Group— Founded

Drugs by trial phase (3 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

vorapaxar

Phase 2 (2 own, 0 via acquisition)

acp-501
medi6570

Indications

Studied for

Atherosclerosis
Coronary Artery Disease
Coronary Disease
Heart Diseases
Infarction
Ischemia
Myocardial Infarction
Myocardial Ischemia
Peripheral Arterial Disease
Peripheral Vascular Diseases
ST Elevation Myocardial Infarction
Stroke

Recent trials (4)

NCT04610892CollaboratorPhase 2Nov 4, 2020
NCT03578809CollaboratorPhase 2Jun 5, 2018
NCT00617123CollaboratorPhase 3Jul 1, 2008
NCT00526474CollaboratorPhase 3Sep 1, 2007

Details

Founded: — Jan 1, 1984
Last known activity: Nov 4, 2020